Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 402 followers
Latest posts
Last updated about 2 hours ago
UCB digs deeper into Bimzelx’s psoriatic arthritis win over Skyrizi
about 2 hours ago
Two months after UCB revealed the success of Bimzelx in a head-to-head...
Roche signs generic Xofluza licensing deal with Medicines Patent Pool for 129 countries
about 2 hours ago
Roche has signed a voluntary license agreement providing its popular influenza antiviral...
White House adds 600 generic meds to TrumpRx purchasing portal
about 2 hours ago
With questions already swirling about the actual affordability impact of the government’s...
Takeda slapped with $885M verdict in pay-for-delay antitrust case
about 5 hours ago
Takeda plans to appeal after a federal jury found it liable in...
Novartis terminates plant contract with Chinese CDMO Porton, threatens $64M in legal claims
about 21 hours ago
A Novartis cross-border partnership is turning into a standoff. The Swiss pharma...
Supreme Court declines to hear IRA challenges from Novo, AZ and more
about 22 hours ago
Following a string of defeats for the industry in challenging the Inflation...
Eli Lilly teams up with Caitlin Clark to bounce sports courts into Indianapolis neighborhoods
about 23 hours ago
Eli Lilly has partnered with basketball star Caitlin Clark’s foundation to open...
AstraZeneca notches key FDA nod in hypertension, with an approval sweetener for Fasenra too
1 day ago
After an impressive phase 3 showing last fall, AstraZeneca’s wager on CinCor...
Merck, Kelun score with sac-TMT in endometrial cancer trial
1 day ago
Merck and Kelun-Biotech have already notched four approvals in China for their...
Bristol Myers looks at Houston for potential $1B manufacturing plant
1 day ago
As Bristol Myers looks for suitable sites for a large U.S. manufacturing...
Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals
1 day ago
Already tracking at $5 billion in annual sales, Enhertu has secured two...
Why pharma isn’t the first voice in the room
1 day ago
Patients arrive informed. Marketers must shift from visibility to usefulness to earn...